Welcome to LookChem.com Sign In|Join Free
  • or
methyl 5-(tritylthio)pentanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1205666-83-6

Post Buying Request

1205666-83-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1205666-83-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1205666-83-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,5,6,6 and 6 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1205666-83:
(9*1)+(8*2)+(7*0)+(6*5)+(5*6)+(4*6)+(3*6)+(2*8)+(1*3)=146
146 % 10 = 6
So 1205666-83-6 is a valid CAS Registry Number.

1205666-83-6Downstream Products

1205666-83-6Relevant academic research and scientific papers

Synthesis of Naphthyridine Carbamate Dimer (NCD) Derivatives Modified with Alkanethiol and Binding Properties of G-G Mismatch DNA

Yamada, Takeshi,Miki, Shouta,Ul'Husna, Anisa,Michikawa, Akiko,Nakatani, Kazuhiko

supporting information, p. 4163 - 4166 (2017/08/23)

A series of new DNA binding molecules NCD-Cn-SH (n = 3, 4, 5, and 6) is reported, which possesses the NCD (naphthyridine carbamate dimer) domain selectively binding to the G-G mismatch in the 5′-CGG-3′/5′-CGG-3′ sequence and a thiol moiety, which undergoes spontaneous dimerization to (NCD-Cn-S)2 upon oxidation under aerobic conditions. The S-S dimer (NCD-Cn-S)2 produced the 1:1 binding complex with improved thermal stability. The dimer binding to the CGG/CGG DNA showed higher positive cooperativity than the binding of monomer and previously synthesized NCTn derivative. The dimerization of NCD-Cn-SH was selectively accelerated on the CGG repeat DNA but not on the CAG repeat DNA.

Method for preparing largazole analogs and uses thereof

-

Page/Page column 38, (2010/03/02)

Analogs of largazole are described herein. Methods of treating cancer and blood disorders using largazole and largazole analogs and pharmaceutical compositions comprising the same are additionally described herein. Methods for preparing largazole analogs are likewise described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1205666-83-6